Barry Bunin

Collaborative Drug Discovery (CDD Vault) CEO is transforming humanitarian & commercial drug discovery...one collaboration at a time. clubhouse: @barrybunin

[Barry Bunin @barrybunin]

Collaborative Drug Discovery Partners with Lilly TuneLab to Make Lilly AI/ML Models Available in CDD Vault https://t.co/afdN0SePsM

[Peter H. Diamandis, MD @PeterDiamandis]

The thing nobody tells you about exponential change is that it feels like nothing is happening right up until the moment everything happens at once.

[Jacob Kimmel @jacobkimmel]

on day 1 @newlimit, we imagined it would take 10+ years to invent real medicines.

our recent results have accelerated the timeline to next year. we've raised a Series C led by @foundersfund alongside @ThriveCapital, @Greenoaks, and many others to bring therapies to the clinic.

medicines for aging are among the most valuable possible technologies. we are grateful to our partners for the opportunity to pursue this mission.

[Ron Alfa @Ronalfa]

You can sell insurance to startups, or you can cure pancreatic cancer.

[NBA Memes @NBAMemes]

Wemby really has the coldest ad in the entire league 💪🏽

[Sarafina El-Badry Nance, PhD @starstrickenSF]

This standing ovation totally brought me to tears.

On Thursday, my dad (stage 4 pancreatic cancer) started a Revolution Medicine trial building upon these results — RMC 5127, which uses the drug celebrated here, Daraxonrasib, with another drug targeting his specific KRAS mutation, G12V.

He’s nearly 2 years into his fight with pancreatic cancer and we have personally felt the impact of this watershed moment. It is a lifeline.

To the incredible, stalwart, brilliant researchers and folks bringing these discoveries to life - thank you. Thank you thank you thank you.

[Barry Bunin @barrybunin]

From WeCroak app, a Steve Jobs quote from beyond

[Barry Bunin @barrybunin]

A personalized cancer vaccine that fights melanoma : NPR https://t.co/ot99XYOL6K

[Barry Bunin @barrybunin]

Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study | Journal of Clinical Oncology https://t.co/egIaXjYZnw

[Barry Bunin @barrybunin]

Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows | Cancer | The Guardian https://t.co/S9C4c0Iq4s

[Barry Bunin @barrybunin]

@HealthcareAIGuy @EliLillyandCo @CBinsights https://t.co/afdN0SePsM

[Barry Bunin @barrybunin]

Check out this article: https://t.co/abPkx2JF5e

[Barry Bunin @barrybunin]

Anthropic S1 https://t.co/EoMX18GD65

[Barry Bunin @barrybunin]

Tackling Antimicrobial Resistance and Glioblastoma with Biology-First AI Models https://t.co/8ka91DKYkE

[Barry Bunin @barrybunin]

Partnership to accelerate drug development - Scientist Live https://t.co/LOKdtqoTyU

[Barry Bunin @barrybunin]

Eli Lilly Expands TuneLab Access As AI Partnerships Shape R&D Outlook https://t.co/HrE72XbWKI

[Barry Bunin @barrybunin]

Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling - BioSpace https://t.co/rgYIFP6hVI

[Barry Bunin @barrybunin]

CDD Vault adds Lilly TuneLab AI to boost drug discovery - SelectScience news https://t.co/LzybSi3KRZ

[Barry Bunin @barrybunin]

Lilly and CDD Open AI Drug Discovery Toolbox for Biotech Innovators - https://t.co/yApYI5hWly https://t.co/DtXq1v1Jrj

[Barry Bunin @barrybunin]

Collaborative Drug Discovery Partners with Lilly TuneLab to Make Lilly AI/ML Models Available in CDD Vault | MarketScreener https://t.co/dLbrkwqADX

[Barry Bunin @barrybunin]

https://t.co/wFd70GUJwg